Evidence map›Paper›PMID 39055590›Full record

ArticleEuropean heart journal supplements : journal of the European Society of Cardiology2024

May Measurement Month 2021: an analysis of blood pressure screening results from Kazakhstan.

Dilyara Mukhtarkhanova, Neil R Poulter, Thomas Beaney, Gaia Kiru, Sima Toopchiani, Gulnara Junusbekova, Meiramgul Kapsimetovna Tundybayeva, Lyazat Baglanova, Tatiana Leonovich, Eldar Ismailov

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European heart journal supplements : journal of the European Society of Cardiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. May Measurement Month 2022: an analysis of blood pressure screening results from Kazakhstan.European heart journal supplements : journal of the European Society of Cardiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dilyara MukhtarkhanovaKazakh Society of Specialists on Arterial Hypertension and Cardiovascular Prevention, 117, Kazybek bi street, Almaty A05E0Y4, Kazakhstan.
Neil R PoulterImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Thomas BeaneyImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Gaia KiruImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Sima ToopchianiImperial Clinical Trials Unit, Imperial College London, Stadium House, 68 Wood Lane, London W12 7RH, UK.
Gulnara JunusbekovaKazakh Society of Specialists on Arterial Hypertension and Cardiovascular Prevention, 117, Kazybek bi street, Almaty A05E0Y4, Kazakhstan.
Meiramgul Kapsimetovna TundybayevaKazakh Society of Specialists on Arterial Hypertension and Cardiovascular Prevention, 117, Kazybek bi street, Almaty A05E0Y4, Kazakhstan.
Lyazat BaglanovaKazakh Society of Specialists on Arterial Hypertension and Cardiovascular Prevention, 117, Kazybek bi street, Almaty A05E0Y4, Kazakhstan.
Tatiana LeonovichKazakh Society of Specialists on Arterial Hypertension and Cardiovascular Prevention, 117, Kazybek bi street, Almaty A05E0Y4, Kazakhstan.
Eldar IsmailovNazarbayev University, Department of Molecular Medicine, 53, Qabanbay Batyr Ave, Nur-Sultan Z05P7P8, Kazakhstan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The May Measurement Month (MMM) screening campaign initiated by the International Society of Hypertension aimed to assess the prevalence of hypertension and associated risk factors to increase and improve population awareness of raised blood pressure (BP) and methods of prevention. The MMM is a cross-sectional survey of adults aged 18 years and over of both sexes who gave informed consent to participate in the survey and to have their BP measured. Kazakhstan participated in the campaign for the first time in 2021. Blood pressure was measured three times on a single occasion, and data on cardiovascular risk factors were collected. A total of 1763 respondents from 4 regions participated in the screening. The mean age was 41 ± 14.4 years; 31.5% of all participants were found to have hypertension, of whom 41.8% were aware, 34.0% on treatment, and only 15.8% controlled (<140/90 mmHg). Significant differences in these rates were found between age and sex groups. The screening campaign confirms low levels of awareness of hypertension and associated risk factors in the population in Kazakhstan and the need for annual screening and implementation of national hypertension control programmes.

Indexed as

Arterial hypertensionBlood pressureControlMay Measurement MonthScreeningTreatment

Identifiers

PMID39055590
PMCPMC11267714

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.